Industry News
Pharmaceutical Industry News
Fierce Pharma’s Angus Liu speaks…
Fierce Pharma's Angus Liu speaks with Harpreet Singh, M.D., chief medical officer at Precision for Medicine and a former FDA oncology division director, about a recent article from agency officials outlining how the FDA plans
In this webinar, which is a…
In this webinar, which is a rebroadcast from the 2025 PODD Conference, business development and technology assessment professionals actively involved in the scouting and evaluating of novel delivery technologies, discuss the constantly evolving topic of partnering.
This webinar addresses how…
This webinar addresses how pharmaceutical organizations are expanding their clinical trial operations globally to support evolving portfolios and react to geopolitics.
Patients and caregivers share…
Patients and caregivers share their perspectives on their clinical trial experiences to help industry with future trial optimization and accessibility.
Why Estrogen Patches For Menopause Are So Hard to Find
Changing attitudes around menopause treatment have driven up demand for hormone therapy.
Less than six months after…
Less than six months after debuting as the first drug that can target a rare tumor type in patients with non-small cell lung cancer, Boehringer Ingelheim’s Hernexeos has quickly widened its reach into the first-line setting
Following an unexpected delay of…
Following an unexpected delay of the CDC vaccine panel's February meeting, the Advisory Committee on Immunization Practices (ACIP) has selected dates next month to convene and discuss, among other matters, COVID-19 vaccine safety.
Already on a roll with its…
Already on a roll with its first-in-class FcRn blocker Vyvgart, argenx has reported successful trial results that could pave the way for the fast-rising blockbuster to reach a new indication—ocular myasthenia gravis.
With a new online resource, Eisai…
With a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer diagnosis.
Sarepta Therapeutics CEO Doug…
Sarepta Therapeutics CEO Doug Ingram announced Wednesday that he will retire by the end of 2026, citing a “shocking and ironic twist of fate” involving the health of his family.
Viatris’ three-year reorganization…
Viatris' three-year reorganization will affect staffers in a range of functions including the company's commercial teams, R&D, medical affairs and manufacturing. Besides the layoffs, the drugmaker also reported a fire in India.
GSK’s every-two-month injection…
GSK's every-two-month injection kept adolescents with HIV virologically suppressed at 96 weeks, GSK's ViiV presented at the recent Conference on Retroviruses and Opportunistic Infections.
The treatment landscape for clear…
The treatment landscape for clear cell renal cell carcinoma could be due for a shake-up following dual breakthroughs from Merck’s Litespark clinical trial program for Welireg. But one critical factor could hinder these Welireg regimens
Pharma logistics are evolving and…
Pharma logistics are evolving and Frontier Scientific Solutions leads the way with a more reliable, temperature-controlled global supply chain.
AI is now routine in how people…
AI is now routine in how people search and process information, with users relying on systems interpreting intent and delivering direct responses, especially in healthcare.
After promising to sell off 7% of…
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and some of its European discovery service assets, which
In developing media plans to reach…
In developing media plans to reach the GLP-1-interested consumer, audio advertising may represent a “blind spot,” according to Anna Clement, director head of industry for SiriusXM Media’s pharma vertical.
When BridgeBio presented its…
When BridgeBio presented its quarterly report on Tuesday, it laid out expectations on the potential threat of generic pricing pressure on Attruby and provided more evidence of the drug's strong launch, possibly giving investors a
Learn about where, how, and when…
Learn about where, how, and when AI is actually making an impact on clinical development based on insights and experiences of working with pharma.
Sanofi has kicked off its…
Sanofi has kicked off its preparations for the 2026 World Cup by becoming an official backer of Boston’s involvement in the soccer showcase.